Misinformation Clouds America’s Most Popular Emergency Contraception

A brand of specialty mozzarella cheeses. A collection of natural-gas storage terminals. And America’s top-selling emergency contraception. At a moment when half of U.S. states stand poised to outlaw or sharply curtail abortion services, the last-ditch pill for women aiming to stave off an unwanted pregnancy rests in the unlikely stewardship of two private equity firms whose investment portfolios range […]

Continue reading »

Changes to Medi-Cal’s Troubled Drug Program Reduce Backlog in California, but Problems Persist

SACRAMENTO, Calif. — The contractor running California’s new Medicaid prescription drug program has addressed shortfalls that earlier this year left thousands of enrollees without critical medications, some languishing on hold for hours as they sought help, state officials told lawmakers Thursday.  But doctors and health care clinics say that some patients are still suffering and that the state and its contractor, […]

Continue reading »

Colchones y remoción de moho: Medi-Cal ofrecerá tratamientos no tradicionales a personas con asma

MADERA, California. – Al crecer en medio de los polvorientos campos agrícolas del Valle Central, Ruby Marentes-Cabrera no puede recordar un momento en el que no fuera difícil respirar. Diagnosticada con asma de pequeña, la estudiante de noveno grado ha llegado a detestar los árboles de pistacho que rodean su casa. El polvo, los pesticidas y otros alérgenos de las […]

Continue reading »

FDA Approves Skytrofa

FDA Approves Skytrofa (lonapegsomatropin-tcgd) for the Once-Weekly Treatment of Pediatric Growth Hormone Deficiency COPENHAGEN, Denmark, Aug. 25, 2021 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon technologies to potentially create new treatments that make a meaningful difference in patients’ lives, today announced that the U.S. Food and Drug Administration (FDA) has approved […]

Continue reading »

FDA Approves Expanded Botox (onabotulinumtoxinA) Label to Include Eight New Muscles to Treat Adults with Upper Limb Spasticity

NORTH CHICAGO, Ill., July 29, 2021 /PRNewswire/ — Allergan, an AbbVie (NYSE: ABBV) company, today announced that the U.S. Food and Drug Administration (FDA) has approved a label expansion of Botox® to include eight new muscles for the treatment of upper limb spasticity in adults. The new muscles for treatment include additional muscles of the elbow and forearm (brachialis, brachioradialis, […]

Continue reading »

Journalists Track Biden’s First 100 Days

Chief Washington correspondent Julie Rovner discussed Biden’s first 100 days on WAMU/NPR’s “1A” on Wednesday. She also joined Wisconsin Public Radio’s “Central Time” to talk about why hospitals aren’t cooperating with price transparency requirements. Click here to hear Rovner on WAMU/NPR Read Rovner’s “The Great Undoing: Which of Trump’s Policies Will Biden Reverse?” Click here to hear Rovner on Wisconsin […]

Continue reading »

Scientists Seek Covid Treatment Answers in Cheap, Older Drugs

Could a decades-old antidepressant be a secret weapon against covid? A few scientists think so, after two small studies showed that fluvoxamine, typically prescribed for obsessive-compulsive disorder, prevented serious illness in all participants who took the pills soon after developing symptoms. It’s an exciting notion: A $10, two-week course of this drug could reduce death and hospitalizations. The drug could […]

Continue reading »

FDA Approves Ponvory

FDA Approves Ponvory (ponesimod) for the Treatment of Adults with Relapsing Multiple Sclerosis TITUSVILLE, N.J. – (March 19, 2021) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) approved Ponvory™ (ponesimod), a once-daily oral selective sphingosine-1-phosphate receptor 1 (S1P1) modulator, to treat adults with relapsing forms of multiple sclerosis (MS), […]

Continue reading »

Micardis® (Telmisartan) Consumer Medicine Information

  Micardis® Tablets Telmisartan Consumer Medicine Information     NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. This page contains answers to some common questions about Micardis®. It does not contain all the information that is known about Micardis®. It does not take the place of talking to your doctor or pharmacist. All medicines have […]

Continue reading »
1 2 3 13